Rosmarinic Acid Restores Colonic Mucus Secretion in Colitis Mice by Regulating Gut Microbiota-Derived Metabolites and the Activation of Inflammasomes
Authors:
- 8 March 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 71 (11) , 4571-4585
Abstract
Maintaining a steady state of mucus barrier is an important potential target for polyphenol to exert its anticolitis activity. This study elucidates the pivotal role of polyphenol rosmaric acid (RA) in regulating the mucus barrier function and alleviating inflammation by identifying its gut microbiota-derived metabolites and evaluating its inhibitory effect on inflammasomes in colitis mice. Results demonstrated that RA treatment promoted the proliferation of goblet cells and restored the level of mucus secretion, especially Muc2. RA reshaped the microbiota of colitis mice, particularly the boost of core probiotics, such as p. Bacteroidaceae, f. Muribaculaceae, g. Muribaculaceae, g. Alistipes, and g. Clostridia_UCG-014. Nontargeted metabonomics and targeted metabonomics confirmed a significant increase in the bile acids and their metabolites (7-sulfocholic acid, stercobilin, chenodeoxycholic acid 3-sulfate, chenodeoxycholic acid sulfate, and ursodeoxycholic acid 3-sulfate), indole metabolites ((R)-2,3-dihydro-3,5-dihydroxy-2-oxo-3-indoleacetic acid, frovatriptan, 3-formyl-6-hydroxyindole, and brassicanal A), and short-chain fatty acids (SCFAs) (acetic acid, butyric acid, isobutyric acid, isovaleric acid, and valeric acid) that contributed to the strengthened mucus barrier function. In addition, being absorbed mainly in the lower digestive tract, RA inhibited the overexpression of inflammasomes (especially NLRP6) that occurred in colitis mice to promote the mucus secretion of goblet cells. These data confirmed that RA, as a promising candidate to enhance gut health, restored colonic mucus secretion in colitis mice by mediating the production of gut microbiota-derived metabolites and the overexpression of inflammasomes. The presented study provides scientific evidence explaining the apparent paradox of low bioavailability and high bioactivity in polyphenols.Keywords
Funding Information
- Guangdong Provincial Department of Science and Technology (2019ZT08N291)
This publication has 59 references indexed in Scilit:
- Metabolism of Cholesterol and Bile Acids by the Gut MicrobiotaPathogens, 2013
- Mucosal Barrier in Ulcerative Colitis and Crohn’s DiseaseGastroenterology Research and Practice, 2013
- Innate immune mechanisms of colitis and colitis-associated colorectal cancerNature Reviews Immunology, 2010
- The role of mucosal immunity and host genetics in defining intestinal commensal bacteriaCurrent Opinion in Gastroenterology, 2010
- Systemic gut microbial modulation of bile acid metabolism in host tissue compartmentsProceedings of the National Academy of Sciences, 2010
- Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and ProgressCurrent Gastroenterology Reports, 2010
- The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammationProceedings of the National Academy of Sciences, 2009
- Mucin Dynamics in Intestinal Bacterial InfectionPLOS ONE, 2008
- Comparative study of the intestinal mucus barrier in normal and inflamed colonGut, 2007
- Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gelProceedings of the National Academy of Sciences, 2006